Which biotech ETFs outperform a key biotech index?

The three top biotech ETFs outperformed a key biotech index and also the broader market over the past year. The biotech ETFs with the best one-year trailing total return are the First Trust NYSE Arca Biotechnology Index Fund, the Invesco Dynamic Biotechnology & Genome ETF, and the VanEck Biotech ETF.

Should you invest in biotech mutual funds or ETFs?

While we recommend ETFs instead of mutual funds because they’re lower cost and more robust, some may still be interested in the best biotech mutual funds: Biotechnology is such an exciting industry to explore, and the possibilities are truly endless.

How many biotech stocks does the iShares biotechnology ETF own?

The ETF currently owns around 275 biotech stocks. Among the iShares Biotechnology ETF's top holdings are some of the biggest biotech stocks based on market capitalization rank. They include Amgen ( AMGN 0.17% ), Gilead Sciences ( GILD 0.0% ), Moderna ( MRNA 1.21% ), and Regeneron Pharmaceuticals ( REGN 1.76% ).

What is VanEck biotech ETF?

VanEck Biotech ETF The VanEck Biotech ETF ( BBH 0.09%) tries to own the most liquid biotech companies based on market cap and trading volume. As such, its approach tends to favor the biggest companies in the biotech sector. The ETF's portfolio can include U.S. companies, as well as foreign companies listed on U.S. stock exchanges.